LUC in southeast Yunnan under different scenarios in 2035. by Bao Zhou (20670850)

Subjects:

Mineral composition of UFC, B, and SF. by Junxia Zhou (14381598)

Subjects:

Spearman’s correlation coefficients between mean scores of each S-Hab-Q factor and the AQ subscales. by Vincenza Tarantino (182506)

Subjects:

Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance by Qiu Fu (10830823)

Subjects:

Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance by Qiu Fu (10830823)

Subjects:

Distribution of ESs and hot and cold spots during the historical period. by Bao Zhou (20670850)

Subjects:

Results of ablation experiments. by Junyan Wang (4738518)

Subjects:

Spatial distribution of ESs. by Bao Zhou (20670850)

Subjects:

Structure diagram of SPDConv. by Junyan Wang (4738518)

Subjects:

Wise-IOU regression diagram. by Junyan Wang (4738518)

Subjects:

Fig 8 - by Junxia Zhou (14381598)

Subjects:

Visualization of detection results. by Junyan Wang (4738518)

Subjects:

Structure diagram of the SE attention mechanism. by Junyan Wang (4738518)

Subjects:

Correspondence of support for SDGs across ESs categories. by Bao Zhou (20670850)

Subjects:

Table1_Asparagus officinalis L. extract exhibits anti-proliferative and anti-invasive effects in endometrial cancer cells and a transgenic mouse model of endometrial cancer.pdf by Ziwei Fang (10115899)

“…The metabolites from asparagus officinalis extracts or asparagus officinalis extracts exhibit significant anti-tumorigenic activity in some pre-clinical models of cancer.…”

Table2_Asparagus officinalis L. extract exhibits anti-proliferative and anti-invasive effects in endometrial cancer cells and a transgenic mouse model of endometrial cancer.pdf by Ziwei Fang (10115899)

“…The metabolites from asparagus officinalis extracts or asparagus officinalis extracts exhibit significant anti-tumorigenic activity in some pre-clinical models of cancer.…”

Decomposition analysis of the changes in prevalence (A), DALYs (B), and mortality (C) rates of IBD among women across global, 5 SDI and 21 GBD regions. by Jiefeng Zhao (9090305)

Subjects:

Health inequalities in the burden of IBD among WCBA. by Jiefeng Zhao (9090305)

Subjects:

Estimated prevalence (A), DALYs (B), and mortality (C) rates for IBD among WCBA by 2040. by Jiefeng Zhao (9090305)

Subjects:

The global changes of AS prevalence, DALYs, and mortality rates of IBD among women from 1990 to 2021. by Jiefeng Zhao (9090305)

Subjects: